Data as of 4:00pm ET
| +0.21 / +0.59%|
The 4 analysts offering 12-month price forecasts for Auxilium Pharmaceuticals Inc have a median target of 33.00, with a high estimate of 33.25 and a low estimate of 32.00. The median estimate represents a -8.51% decrease from the last price of 36.07.
The current consensus among 6 polled investment analysts is to Hold stock in Auxilium Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.